Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page adds a new revision entry 'Revision: v3.3.3' and removes 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer/history section.
    Difference
    0.2%
    Check dated 2025-12-22T01:20:46.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a new revision label 'Revision: v3.3.2' in the history and removed the previous label 'Revision: v3.3.1'. This is a minor system update.
    Difference
    0.1%
    Check dated 2025-11-30T10:17:03.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page history lists a new Revision: v3.3.1 and the removal of Revision: v3.2.0 in the version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-23T07:55:09.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Removal of the government funding notice banner from the page header; the core study history content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-16T05:50:48.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Version 13 (2025-06-13) was added, showing updates to the Study Status and Recruitment Status in the record history.
    Difference
    0.1%
    Check dated 2025-11-01T23:59:02.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.
    Difference
    12%
    Check dated 2025-10-04T03:15:52.000Z thumbnail image

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.